| |
FASTING
INHIBITS SEIZURE SUSCEPTIBILITY |
|
|
| |
| |
|
2004
Biology Department, Boston College,
Chestnut Hill, MA, USA.
BACKGROUND: The high fat, low carbohydrate
ketogenic diet (KD) was developed as an alternative to
fasting for seizure management. While the mechanisms by
which fasting and the KD inhibit seizures remain speculative,
alterations in brain energy metabolism are likely involved.
We previously showed that caloric restriction (CR) inhibits
seizure susceptibility by reducing blood glucose in the
epileptic EL mouse, a natural model for human multifactorial
idiopathic epilepsy. In this study, we compared the antiepileptic
and anticonvulsant efficacy of the KD with that of CR
in adult EL mice with active epilepsy. EL mice that experienced
at least 15 recurrent complex partial seizures were fed
either a standard diet unrestricted (SD-UR) or restricted
(SD-R), and either a KD unrestricted (KD-UR) or restricted
(KD-R). All mice were fasted for 14 hrs prior to diet
initiation. A new experimental design was used where each
mouse in the diet-restricted groups served as its own
control to achieve a 20-23% body weight reduction. Seizure
susceptibility, body weights, and the levels of plasma
glucose and beta-hydroxybutyrate were measured once/week
over a nine-week treatment period. RESULTS: Body weights
and blood glucose levels remained high over the testing
period in the SD-UR and the KD-UR groups, but were significantly
(p < 0.001) reduced in the SD-R and KD-R groups. Plasma
beta-hydroxybutyrate levels were significantly (p <
0.001) increased in the SD-R and KD-R groups compared
to their respective UR groups. Seizure susceptibility
remained high in both UR-fed groups throughout the study,
but was significantly reduced after three weeks in both
R-fed groups. CONCLUSIONS: The results indicate that seizure
susceptibility in EL mice is dependent on plasma glucose
levels and that seizure control is more associated with
the amount than with the origin of dietary calories. Also,
CR underlies the antiepileptic and anticonvulsant action
of the KD in EL mice. A transition from glucose to ketone
bodies for energy is predicted to manage EL epileptic
seizures through multiple integrated changes of inhibitory
and excitatory neural systems.
|
|
|
2001
Biology Department, Boston College,
Chestnut Hill, Massachusetts 02167, USA.
Caloric restriction (CR) involves
underfeeding and has long been recognized as a dietary
therapy that improves health and increases longevity.
In contrast to severe fasting or starvation, CR reduces
total food intake without causing nutritional deficiencies.
Although fasting has been recognized as an effective antiseizure
therapy since the time of the ancient Greeks, the mechanism
by which fasting inhibits seizures remains obscure. The
influence of CR on seizure susceptibility was investigated
at both juvenile (30 days) and adult (70 days) ages in
the EL mouse, a genetic model of multifactorial idiopathic
epilepsy. METHODS: The juvenile EL mice were separated
into two groups and fed standard lab chow either ad libitum
(control, n=18) or with a 15% CR diet (treated, n=17).
The adult EL mice were separated into three groups; control
(n=15), 15% CR (n=6), and 30% CR (n=3). Body weights,
seizure susceptibility, and the levels of blood glucose
and ketones (beta-hydroxybutyrate) were measured over
a 10-week treatment period. Simple linear regression and
multiple logistic regression were used to analyze the
relations among seizures, glucose, and ketones. RESULTS:
CR delayed the onset and reduced the incidence of seizures
at both juvenile and adult ages and was devoid of adverse
side effects. Furthermore, mild CR (15%) had a greater
antiepileptogenic effect than the well-established high-fat
ketogenic diet in the juvenile mice. The CR-induced changes
in blood glucose levels were predictive of both blood
ketone levels and seizure susceptibility. CONCLUSIONS:
We propose that CR may reduce seizure susceptibility in
EL mice by reducing brain glycolytic energy. Our preclinical
findings suggest that CR may be an effective antiseizure
dietary therapy for human seizure disorders.
|
|
|